Mrs. Lisa Diane Noe, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1030 E Cherry St, Cushing, OK 74023 Phone: 918-225-0616 Fax: 918-225-3740 |
Mr. Joseph A Cardello, P.A. Physician Assistant - Surgical Medicare: Not Enrolled in Medicare Practice Location: 2340 E Main St, Cushing, OK 74023 Phone: 918-225-6904 Fax: 918-225-4559 |
Amber Kathryn Reinecke, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1025 E 2nd St, Cushing, OK 74023 Phone: 918-225-3627 Fax: 918-225-0871 |
News Archive
The World Health Organization today certified Paraguay as having eliminated malaria, the first country in the Americas to be granted this status since Cuba in 1973.
A number of important questions and issues should be addressed before changes are made to the guidelines for the diagnosis of gestational diabetes, according to a new article by University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., published online in the American Journal of Obstetrics and Gynecology on Oct. 31. The article publishes in advance of a new National Institutes of Health (NIH) initiative to reconsider diagnostic guidelines for the condition.
A new study just released in the American Journal of Clinical Nutrition found that different flavors of peanuts – salted, spicy, honey-roasted, or unsalted – result in positive health benefits. The study, "A Randomized Trial on the Effects of Flavorings on the Health Benefits of Daily Peanut Consumption," was conducted at Purdue University and included over 150 men and women who incorporated peanuts into their daily diet for 12 weeks.
We're told that gridlock, procedural holds, partisanship and extreme ideology are preventing members of Congress from working together. While some of this analysis is true - Washington is petty, partisan and shortsighted - few are acknowledging that Congress does enjoy remarkable unity in one critical area: spending beyond our means (Sen. Tom Coburn, 2/26).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA Silencing: Mechanism, Biology, and Application" Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam's therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington's disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.
› Verified 1 days ago